Agenda

Monday, December 7, 2026. All times Eastern.

9:00 a.m.

Welcome and Opening Remarks

David A. Ricks, Chair and Chief Executive Officer

R&D Strategy

Daniel M. Skovronsky, M.D., Ph.D. Chief Scientific and Product Officer and President, Lilly Research Laboratories

Andrew Adams, Ph.D., Group Vice President, Molecule Discovery

Impact Obesity at Scale

Kenneth Custer, Ph.D., Executive Vice President and President, Lilly Cardiometabolic Health

Ruth Gimeno, Ph.D., Group Vice President, Diabetes & Metabolic Research

Q&A Panel

Daniel M. Skovronsky, M.D., Ph.D., Andrew Adams, Ph.D., Kenneth Custer, Ph.D. and Ruth Gimeno, Ph.D.

10:30 a.m.

Break

10:45 a.m.

The Next Big Ideas

Adrienne Brown, Executive Vice President and President, Lilly Immunology

Carole Ho, Executive Vice President and President, Lilly Neuroscience

Jacob Van Naarden, Executive Vice President; President, Lilly Oncology and Head of Corporate Business Development

and Lilly Scientific Leaders

Includes two Q&A panels.

Investing for Growth

Lucas Montarce, Executive Vice President and Chief Financial Officer

Closing Panel and Q&A

David A. Ricks, Lucas Montarce and Ilya Yuffa, Executive Vice President and President, Lilly USA and Global Customer Capabilities

1:00 p.m.

Webcast concludes